 | • レポートコード：QFJ1-4906 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、スティル病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・スティル病治療の市場動向 ・企業の競争状況、市場シェア ・スティル病治療の種類別市場規模と予測2016-2027（コルチコステロイド、トシリズマブ、カナキヌマブ、アナキンラ、その他） ・スティル病治療の用途別市場規模と予測2016-2027（小売薬局、病院薬局、オンライン薬局） ・スティル病治療の北米市場規模2016-2027（アメリカ、カナダ） ・スティル病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・スティル病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・スティル病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・スティル病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB2 Bio Ltd、Novartis AG、F. Hoffmann-La Roche Ltd、Swedish Orphan Biovitrum AB、Jubilant、Hikma Pharmaceuticals PLC、Teva Pharmaceutical Industries Ltd、Viatris、Horizon Therapeutics plc、Sun Pharmaceutical Industries Ltd、Zydus Cadila、Amneal Pharmaceuticals LLC、Dr Reddy's Laboratories Ltd、Fresenius Kabi AG） ・結論 |
Still’s disease is a rare rheumatic condition. This condition is characterized by biological and clinical symptoms such as high spiking fever, joint swelling, muscle pain, sore throat, increased number of white cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for still’s disease can be classified into 2 categories, namely symptomatic treatments and effective therapies. Symptomatic treatments can be initiated immediately, even when the diagnosis has not been established whereas, effective therapies are designed to treat the condition more efficiently to eradicate the symptoms of the disease.
Market Analysis and Insights: Global Still’s Disease Treatment Market
The global Still’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Still’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Still’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Still’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Still’s Disease Treatment market.
Global Still’s Disease Treatment Scope and Market Size
Still’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Still’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Tocilizumab
Canakinumab
Anakinra
Others
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AB2 Bio Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Swedish Orphan Biovitrum AB
Jubilant
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd
Viatris
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Amneal Pharmaceuticals LLC
Dr Reddy’s Laboratories Ltd
Fresenius Kabi AG
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Still’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Tocilizumab
1.2.4 Canakinumab
1.2.5 Anakinra
1.2.6 Others
1.3 Market by Application
1.3.1 Global Still’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Still’s Disease Treatment Market Perspective (2016-2027)
2.2 Still’s Disease Treatment Growth Trends by Regions
2.2.1 Still’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Still’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Still’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Still’s Disease Treatment Industry Dynamic
2.3.1 Still’s Disease Treatment Market Trends
2.3.2 Still’s Disease Treatment Market Drivers
2.3.3 Still’s Disease Treatment Market Challenges
2.3.4 Still’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Still’s Disease Treatment Players by Revenue
3.1.1 Global Top Still’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Still’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Still’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Still’s Disease Treatment Revenue
3.4 Global Still’s Disease Treatment Market Concentration Ratio
3.4.1 Global Still’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Still’s Disease Treatment Revenue in 2020
3.5 Still’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Still’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Still’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Still’s Disease Treatment Breakdown Data by Type
4.1 Global Still’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Still’s Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Still’s Disease Treatment Breakdown Data by Application
5.1 Global Still’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Still’s Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Still’s Disease Treatment Market Size (2016-2027)
6.2 North America Still’s Disease Treatment Market Size by Type
6.2.1 North America Still’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Still’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Still’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Still’s Disease Treatment Market Size by Application
6.3.1 North America Still’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Still’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Still’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Still’s Disease Treatment Market Size by Country
6.4.1 North America Still’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Still’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Still’s Disease Treatment Market Size (2016-2027)
7.2 Europe Still’s Disease Treatment Market Size by Type
7.2.1 Europe Still’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Still’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Still’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Still’s Disease Treatment Market Size by Application
7.3.1 Europe Still’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Still’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Still’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Still’s Disease Treatment Market Size by Country
7.4.1 Europe Still’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Still’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Still’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Still’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Still’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Still’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Still’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Still’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Still’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Still’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Still’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Still’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Still’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Still’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Still’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Still’s Disease Treatment Market Size by Type
9.2.1 Latin America Still’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Still’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Still’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Still’s Disease Treatment Market Size by Application
9.3.1 Latin America Still’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Still’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Still’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Still’s Disease Treatment Market Size by Country
9.4.1 Latin America Still’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Still’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Still’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Still’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Still’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Still’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Still’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Still’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Still’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Still’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Still’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Still’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Still’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Still’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB2 Bio Ltd
11.1.1 AB2 Bio Ltd Company Details
11.1.2 AB2 Bio Ltd Business Overview
11.1.3 AB2 Bio Ltd Still’s Disease Treatment Introduction
11.1.4 AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2016-2021)
11.1.5 AB2 Bio Ltd Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Still’s Disease Treatment Introduction
11.2.4 Novartis AG Revenue in Still’s Disease Treatment Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Still’s Disease Treatment Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Swedish Orphan Biovitrum AB
11.4.1 Swedish Orphan Biovitrum AB Company Details
11.4.2 Swedish Orphan Biovitrum AB Business Overview
11.4.3 Swedish Orphan Biovitrum AB Still’s Disease Treatment Introduction
11.4.4 Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2016-2021)
11.4.5 Swedish Orphan Biovitrum AB Recent Development
11.5 Jubilant
11.5.1 Jubilant Company Details
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Still’s Disease Treatment Introduction
11.5.4 Jubilant Revenue in Still’s Disease Treatment Business (2016-2021)
11.5.5 Jubilant Recent Development
11.6 Hikma Pharmaceuticals PLC
11.6.1 Hikma Pharmaceuticals PLC Company Details
11.6.2 Hikma Pharmaceuticals PLC Business Overview
11.6.3 Hikma Pharmaceuticals PLC Still’s Disease Treatment Introduction
11.6.4 Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2016-2021)
11.6.5 Hikma Pharmaceuticals PLC Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 Viatris
11.8.1 Viatris Company Details
11.8.2 Viatris Business Overview
11.8.3 Viatris Still’s Disease Treatment Introduction
11.8.4 Viatris Revenue in Still’s Disease Treatment Business (2016-2021)
11.8.5 Viatris Recent Development
11.9 Horizon Therapeutics plc
11.9.1 Horizon Therapeutics plc Company Details
11.9.2 Horizon Therapeutics plc Business Overview
11.9.3 Horizon Therapeutics plc Still’s Disease Treatment Introduction
11.9.4 Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2016-2021)
11.9.5 Horizon Therapeutics plc Recent Development
11.10 Sun Pharmaceutical Industries Ltd
11.10.1 Sun Pharmaceutical Industries Ltd Company Details
11.10.2 Sun Pharmaceutical Industries Ltd Business Overview
11.10.3 Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
11.10.4 Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2016-2021)
11.10.5 Sun Pharmaceutical Industries Ltd Recent Development
11.11 Zydus Cadila
11.11.1 Zydus Cadila Company Details
11.11.2 Zydus Cadila Business Overview
11.11.3 Zydus Cadila Still’s Disease Treatment Introduction
11.11.4 Zydus Cadila Revenue in Still’s Disease Treatment Business (2016-2021)
11.11.5 Zydus Cadila Recent Development
11.12 Amneal Pharmaceuticals LLC
11.12.1 Amneal Pharmaceuticals LLC Company Details
11.12.2 Amneal Pharmaceuticals LLC Business Overview
11.12.3 Amneal Pharmaceuticals LLC Still’s Disease Treatment Introduction
11.12.4 Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2016-2021)
11.12.5 Amneal Pharmaceuticals LLC Recent Development
11.13 Dr Reddy’s Laboratories Ltd
11.13.1 Dr Reddy’s Laboratories Ltd Company Details
11.13.2 Dr Reddy’s Laboratories Ltd Business Overview
11.13.3 Dr Reddy’s Laboratories Ltd Still’s Disease Treatment Introduction
11.13.4 Dr Reddy’s Laboratories Ltd Revenue in Still’s Disease Treatment Business (2016-2021)
11.13.5 Dr Reddy’s Laboratories Ltd Recent Development
11.14 Fresenius Kabi AG
11.14.1 Fresenius Kabi AG Company Details
11.14.2 Fresenius Kabi AG Business Overview
11.14.3 Fresenius Kabi AG Still’s Disease Treatment Introduction
11.14.4 Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2016-2021)
11.14.5 Fresenius Kabi AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Still’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Tocilizumab
Table 4. Key Players of Canakinumab
Table 5. Key Players of Anakinra
Table 6. Key Players of Others
Table 7. Global Still’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Still’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Still’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Still’s Disease Treatment Market Share by Regions (2016-2021)
Table 11. Global Still’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Still’s Disease Treatment Market Share by Regions (2022-2027)
Table 13. Still’s Disease Treatment Market Trends
Table 14. Still’s Disease Treatment Market Drivers
Table 15. Still’s Disease Treatment Market Challenges
Table 16. Still’s Disease Treatment Market Restraints
Table 17. Global Still’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Still’s Disease Treatment Market Share by Players (2016-2021)
Table 19. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Still’s Disease Treatment as of 2020)
Table 20. Ranking of Global Top Still’s Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Still’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Still’s Disease Treatment Product Solution and Service
Table 24. Date of Enter into Still’s Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Still’s Disease Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Still’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Still’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Still’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Still’s Disease Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Still’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Still’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Still’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Still’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Still’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Still’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Still’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Still’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Still’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Still’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Still’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Still’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Still’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Still’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Still’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Still’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Still’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Still’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Still’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Still’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Still’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Still’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Still’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Still’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Still’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Still’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Still’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Still’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. AB2 Bio Ltd Company Details
Table 65. AB2 Bio Ltd Business Overview
Table 66. AB2 Bio Ltd Still’s Disease Treatment Product
Table 67. AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 68. AB2 Bio Ltd Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Still’s Disease Treatment Product
Table 72. Novartis AG Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Swedish Orphan Biovitrum AB Company Details
Table 80. Swedish Orphan Biovitrum AB Business Overview
Table 81. Swedish Orphan Biovitrum AB Still’s Disease Treatment Product
Table 82. Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 83. Swedish Orphan Biovitrum AB Recent Development
Table 84. Jubilant Company Details
Table 85. Jubilant Business Overview
Table 86. Jubilant Still’s Disease Treatment Product
Table 87. Jubilant Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 88. Jubilant Recent Development
Table 89. Hikma Pharmaceuticals PLC Company Details
Table 90. Hikma Pharmaceuticals PLC Business Overview
Table 91. Hikma Pharmaceuticals PLC Still’s Disease Treatment Product
Table 92. Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 93. Hikma Pharmaceuticals PLC Recent Development
Table 94. Teva Pharmaceutical Industries Ltd Company Details
Table 95. Teva Pharmaceutical Industries Ltd Business Overview
Table 96. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 97. Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 98. Teva Pharmaceutical Industries Ltd Recent Development
Table 99. Viatris Company Details
Table 100. Viatris Business Overview
Table 101. Viatris Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 102. Viatris Recent Development
Table 103. Horizon Therapeutics plc Company Details
Table 104. Horizon Therapeutics plc Business Overview
Table 105. Horizon Therapeutics plc Still’s Disease Treatment Product
Table 106. Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 107. Horizon Therapeutics plc Recent Development
Table 108. Sun Pharmaceutical Industries Ltd Company Details
Table 109. Sun Pharmaceutical Industries Ltd Business Overview
Table 110. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 111. Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 112. Sun Pharmaceutical Industries Ltd Recent Development
Table 113. Zydus Cadila Company Details
Table 114. Zydus Cadila Business Overview
Table 115. Zydus Cadila Still’s Disease Treatment Product
Table 116. Zydus Cadila Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 117. Zydus Cadila Recent Development
Table 118. Amneal Pharmaceuticals LLC Company Details
Table 119. Amneal Pharmaceuticals LLC Business Overview
Table 120. Amneal Pharmaceuticals LLC Still’s Disease Treatment Product
Table 121. Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 122. Amneal Pharmaceuticals LLC Recent Development
Table 123. Dr Reddy's Laboratories Ltd Company Details
Table 124. Dr Reddy's Laboratories Ltd Business Overview
Table 125. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Product
Table 126. Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 127. Dr Reddy's Laboratories Ltd Recent Development
Table 128. Fresenius Kabi AG Company Details
Table 129. Fresenius Kabi AG Business Overview
Table 130. Fresenius Kabi AG Still’s Disease Treatment Product
Table 131. Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2016-2021) & (US$ Million)
Table 132. Fresenius Kabi AG Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Still’s Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Tocilizumab Features
Figure 4. Canakinumab Features
Figure 5. Anakinra Features
Figure 6. Others Features
Figure 7. Global Still’s Disease Treatment Market Share by Application: 2020 VS 2027
Figure 8. Retail Pharmacies Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Still’s Disease Treatment Report Years Considered
Figure 12. Global Still’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Still’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Still’s Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Still’s Disease Treatment Market Share by Regions (2022-2027)
Figure 16. Global Still’s Disease Treatment Market Share by Players in 2020
Figure 17. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Still’s Disease Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Still’s Disease Treatment Revenue in 2020
Figure 19. Global Still’s Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Still’s Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Still’s Disease Treatment Market Share by Type (2016-2027)
Figure 23. North America Still’s Disease Treatment Market Share by Application (2016-2027)
Figure 24. North America Still’s Disease Treatment Market Share by Country (2016-2027)
Figure 25. United States Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Still’s Disease Treatment Market Share by Type (2016-2027)
Figure 29. Europe Still’s Disease Treatment Market Share by Application (2016-2027)
Figure 30. Europe Still’s Disease Treatment Market Share by Country (2016-2027)
Figure 31. Germany Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Still’s Disease Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Still’s Disease Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Still’s Disease Treatment Market Share by Region (2016-2027)
Figure 41. China Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Still’s Disease Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Still’s Disease Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Still’s Disease Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Still’s Disease Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Still’s Disease Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Still’s Disease Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Still’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AB2 Bio Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 63. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 64. Jubilant Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 65. Hikma Pharmaceuticals PLC Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 67. Viatris Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 68. Horizon Therapeutics plc Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 69. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 70. Zydus Cadila Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 71. Amneal Pharmaceuticals LLC Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 72. Dr Reddy's Laboratories Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 73. Fresenius Kabi AG Revenue Growth Rate in Still’s Disease Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の非びらん性胃食道逆流症治療市場規模・現状・予測（2021年-2027年） Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). Market Analysis and Insights: Global Nonerosive Reflux Disease Treatment Market The global Nonerosi…- 世界のドライアイ診断＆治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Dry Eye Disease Diagnostics and Treatment Market The global Dry Eye Disease Diagnostics and Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in anal…
- 世界のデント病治療市場規模・現状・予測（2021年-2027年） Dent disease treatment offers treatment to rare genetic kidney disorder. To reduce the quantity of calcium in the urine and to decrease the recurrent occurrence of nephrolithiasis, dent disease treatment plays an important role. Additionally, dent disease treatment cures the kidney calcifications wh…
- 世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market The global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is projected to reach US$ 16110 million by 2027, from US$ 12890 million in 2020, at a CAGR of 2.8% during 2021-2027. With i…
- 世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …